tiprankstipranks
Advertisement
Advertisement

HK:6855 Stock Latest News

Ascentage Pharma assumed with an Outperform at Oppenheimer
The FlyAscentage Pharma assumed with an Outperform at Oppenheimer
4d ago
AAPG
Ascentage Pharma announces clinical updates from EHA2026
PremiumThe Fly
Ascentage Pharma announces clinical updates from EHA2026
4d ago
AAPG
Ascentage Pharma Showcases Broad Leukemia Data for Olverembatinib and Lisaftoclax at EHA2026
PremiumCompany Announcements
Ascentage Pharma Showcases Broad Leukemia Data for Olverembatinib and Lisaftoclax at EHA2026
4d ago
6855
Ascentage Pharma Trustee Buys Shares to Fund 2022 RSU Scheme
PremiumCompany Announcements
Ascentage Pharma Trustee Buys Shares to Fund 2022 RSU Scheme
8d ago
6855
Ascentage Pharma Trustee Buys Shares to Fund 2022 RSU Incentive Scheme
PremiumCompany Announcements
Ascentage Pharma Trustee Buys Shares to Fund 2022 RSU Incentive Scheme
9d ago
6855
Ascentage Pharma initiated with a Buy at B. Riley
PremiumThe FlyAscentage Pharma initiated with a Buy at B. Riley
9d ago
AAPG
Ascentage Pharma presents data on olverembatinib
Premium
The Fly
Ascentage Pharma presents data on olverembatinib
18d ago
AAPG
Ascentage Pharma presents data from Phase 1b study of olverembatinib
Premium
The Fly
Ascentage Pharma presents data from Phase 1b study of olverembatinib
18d ago
AAPG
Ascentage Pharma presents first dataset of alrizomadlin
PremiumThe Fly
Ascentage Pharma presents first dataset of alrizomadlin
18d ago
AAPG
Ascentage Pharma Trustee Buys Shares to Fund 2022 RSU Scheme
PremiumCompany Announcements
Ascentage Pharma Trustee Buys Shares to Fund 2022 RSU Scheme
22d ago
6855
Ascentage Pharma Adds 100,000 Shares to 2022 RSU Trust in Latest On‑Market Buy
PremiumCompany Announcements
Ascentage Pharma Adds 100,000 Shares to 2022 RSU Trust in Latest On‑Market Buy
23d ago
6855
Ascentage Pharma Sheds Biotech Marker After Meeting HKEX Revenue and Market Cap Tests
PremiumCompany Announcements
Ascentage Pharma Sheds Biotech Marker After Meeting HKEX Revenue and Market Cap Tests
23d ago
6855
Ascentage Pharma Showcases Promising Olverembatinib Data in Multiple Leukemia Trials at ASCO 2026
PremiumCompany AnnouncementsAscentage Pharma Showcases Promising Olverembatinib Data in Multiple Leukemia Trials at ASCO 2026
28d ago
6855
Ascentage Pharma Shareholders Approve All Resolutions at 2026 AGM
Premium
Company Announcements
Ascentage Pharma Shareholders Approve All Resolutions at 2026 AGM
30d ago
6855
Ascentage Pharma: Buy Rating Reiterated on Advancing CML/ALL Pipeline and DCF-Supported Unchanged $48 Price Target
Premium
Ratings
Ascentage Pharma: Buy Rating Reiterated on Advancing CML/ALL Pipeline and DCF-Supported Unchanged $48 Price Target
1M ago
AAPG
Ascentage Pharma Adds Executive Equity Grants to AGM Agenda and Updates Proxy Process
PremiumCompany Announcements
Ascentage Pharma Adds Executive Equity Grants to AGM Agenda and Updates Proxy Process
2M ago
6855
Ascentage Pharma Sets AGM to Approve 2025 Accounts, Board Mandates and Share Issue Authority
PremiumCompany Announcements
Ascentage Pharma Sets AGM to Approve 2025 Accounts, Board Mandates and Share Issue Authority
2M ago
6855
Ascentage Pharma initiated with a Buy at Deutsche Bank
PremiumThe Fly
Ascentage Pharma initiated with a Buy at Deutsche Bank
2M ago
AAPG
Ascentage Pharma to Showcase Six Cancer Drug Studies at 2026 ASCO Meeting
PremiumCompany Announcements
Ascentage Pharma to Showcase Six Cancer Drug Studies at 2026 ASCO Meeting
2M ago
6855
Ascentage Pharma Grants New RSUs to Top Executives Under 2022 Incentive Scheme
PremiumCompany AnnouncementsAscentage Pharma Grants New RSUs to Top Executives Under 2022 Incentive Scheme
2M ago
6855
Ascentage Pharma Showcases Promising Combination Oncology Data at AACR 2026
Premium
Company Announcements
Ascentage Pharma Showcases Promising Combination Oncology Data at AACR 2026
2M ago
6855
Ascentage Pharma management to meet with Piper Sandler
Premium
The Fly
Ascentage Pharma management to meet with Piper Sandler
2M ago
AAPG

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >